GFPC
Global Financial Private Client’s iShares Biotechnology ETF IBB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-2,601
| Closed | -$333K | – | 844 |
|
2025
Q1 | $333K | Buy |
2,601
+1,961
| +306% | +$251K | 0.13% | 162 |
|
2024
Q4 | $84.6K | Hold |
640
| – | – | 0.03% | 277 |
|
2024
Q3 | $93.2K | Hold |
640
| – | – | 0.04% | 269 |
|
2024
Q2 | $87.8K | Sell |
640
-6
| -0.9% | -$824 | 0.04% | 250 |
|
2024
Q1 | $88.4K | Sell |
646
-1,640
| -72% | -$224K | 0.04% | 252 |
|
2023
Q4 | $311K | Buy |
2,286
+138
| +6% | +$18.7K | 0.15% | 148 |
|
2023
Q3 | $259K | Sell |
2,148
-2,661
| -55% | -$321K | 0.13% | 150 |
|
2023
Q2 | $610K | Buy |
4,809
+33
| +0.7% | +$4.19K | 0.3% | 81 |
|
2023
Q1 | $620K | Sell |
4,776
-257
| -5% | -$33.4K | 0.32% | 75 |
|
2022
Q4 | $661K | Buy |
5,033
+1,517
| +43% | +$199K | 0.37% | 64 |
|
2022
Q3 | $419K | Buy |
3,516
+2,827
| +410% | +$337K | 0.24% | 97 |
|
2022
Q2 | $82.8K | Hold |
689
| – | – | 0.05% | 209 |
|
2022
Q1 | $91.7K | Sell |
689
-2,138
| -76% | -$284K | 0.04% | 203 |
|
2021
Q4 | $431K | Buy |
2,827
+76
| +3% | +$11.6K | 0.21% | 96 |
|
2021
Q3 | $437K | Sell |
2,751
-210
| -7% | -$33.4K | 0.22% | 100 |
|
2021
Q2 | $489K | Buy |
2,961
+633
| +27% | +$105K | 0.27% | 88 |
|
2021
Q1 | $353K | Buy |
2,328
+340
| +17% | +$51.5K | 0.25% | 84 |
|
2020
Q4 | $301K | Buy |
1,988
+152
| +8% | +$23K | 0.24% | 82 |
|
2020
Q3 | $251K | Sell |
1,836
-107
| -6% | -$14.6K | 0.22% | 84 |
|
2020
Q2 | $267K | Sell |
1,943
-3
| -0.2% | -$412 | 0.23% | 88 |
|
2020
Q1 | $202K | Buy |
1,946
+6
| +0.3% | +$623 | 0.21% | 97 |
|
2019
Q4 | $234K | Buy |
+1,940
| New | +$234K | 0.2% | 103 |
|